Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Response Biomedical Corp. logo — Our Tests. Your Total Solution.

Response Biomedical Corp.

Our Tests. Your Total Solution.

Founded 1991 Canada Canada 74 employees Post-IPO Debt Biotechnology, Health Care +1

General Information

Company Name Response Biomedical Corp.
Founded Year 1991
Location Canada Canada
Employees 74
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Response Biomedical Corp.. To contact Response Biomedical Corp., visit responsebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Response Biomedical Corp.

Response Biomedical Corp. is a Canadian-based company founded in 1991. The company's slogan, "Our Tests. Your Total Solution," reflects its focus on developing, manufacturing, and marketing the RAMP® system. This rapid diagnostics platform is designed to deliver lab-quality performance for efficient patient management in acute care settings. With a wide range of markers available, including Troponin I, CK-MB, Myoglobin, NT-proBNP, D-dimer, and Procalcitonin, RAMP® has established itself as a global leader in comprehensive acute care testing. The company's tests aid in the diagnosis of Acute Myocardial Infarction, Heart Failure, and Sepsis, contributing to effective and efficient patient care. In terms of investment, Response Biomedical Corp. received a significant Post-IPO Debt investment on 12 February 2014. The investors behind this investment are not explicitly mentioned, but it showcases the company's attractiveness to potential backers. Response Biomedical Corp. operates within the Biotechnology, Health Care, and Manufacturing industries, demonstrating its versatility and cross-sector potential. With a strong focus on providing innovative diagnostic solutions for acute care, the company is positioned to further establish its presence in the global healthcare market.

Taxonomy: Rapid Diagnostics, Acute Care Testing, Diagnostic Testing Platforms, Cardiac Markers, Point-of-Care Testing, Infectious Disease Testing, Biodefense Testing, Environmental Testing, Laboratory Quality Results, Medical Diagnostics, Clinical Testing, Sepsis Diagnosis, Women's Health, Precision Medicine

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt Undisclosed -
12 Feb 2014
Post IPO Equity Undisclosed -
10 Oct 2013
Post IPO Equity Undisclosed -
05 Jan 2012
Post IPO Debt Undisclosed -
01 Dec 2011
Post IPO Equity Undisclosed -
12 Aug 2010
Post IPO Equity Undisclosed -
28 May 2009

Response Biomedical Corp. Alternatives & Competitors

Response Biomedical Corp. vs
Cleveland HeartLab, Inc.
Cleveland HeartLab, Inc. United States

Specializing in next-generation cardiovascular disease prevention, diagnosis & management and inflam...

Venture round
63 employees
Biotechnology, Health Care
Response Biomedical Corp. vs
Premier Medical Corporation Private Limited
Premier Medical Corporation Private Limited India

Commitment to Quality and Care

82 employees
Biotechnology, Hardware
Response Biomedical Corp. vs
EMPE Diagnostics
EMPE Diagnostics Sweden

Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resource-limited...

Series A
27 employees
Biotechnology, Health Care
Also compare with: Response Biomedical Corp. vs STAT-Dx STAT-Dx

FAQ About Response Biomedical Corp.

Our Tests. Your Total Solution.
Response Biomedical Corp. was founded in 1991.
Response Biomedical Corp. is headquartered in Canada.
Response Biomedical Corp. operates in Biotechnology, Health Care and Manufacturing. Its work centres on Rapid Diagnostics, Acute Care Testing, Diagnostic Testing Platforms and Cardiac Markers.
Response Biomedical Corp. has approximately 74 employees.
Response Biomedical Corp. has completed 6 funding rounds. The latest funding stage is Post-IPO Debt.
Top alternatives and competitors to Response Biomedical Corp. include Cleveland HeartLab, Inc., Premier Medical Corporation Private Limited, EMPE Diagnostics, True Diagnostics™, Microplate Dx Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Response Biomedical Corp. and Cleveland HeartLab, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Response Biomedical Corp., https://bouncewatch.com/company/response-biomedical-corp, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes